Altered expression of CD44 and variant isoforms in human adenocarcinoma of the endocervix during progression

Gynecologic Oncology

Volumn 75, Issue 1, 1999, Pages 84-90

  Lu, Di ^a   Tawfik, Ossama ^a,b   Pantazis, Cooley ^c,d   Hobart, Wendy ^b   Chapman, Julia ^b   Iczkowski, Kenneth ^e  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d Munroe Regional Med Center   (United States)

^e READING HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

CD44; Endocervical adenocarcinoma; Variant isoforms 4, 6, 7, and 9

Indexed keywords

ALLOANTIGEN; CELL ADHESION MOLECULE; GENE PRODUCT; HERMES ANTIGEN;

ADENOCARCINOMA; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; METASTASIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

EID: 0032878098     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5517     Document Type: Article

References (40)

1. Vesterinen E, Forss M, Nieminen U. Increase of cervical adenocarcinoma. A report of 520 cases of cervical carcinomas including 112 tumors with glandular elements. Gynecol Oncol. 33:1989;49-53.
2. Goodman H M, Buttlar C A, Niloff J M, Welch W R, Marck A, Feuer E J, Lahman E A, Jenison E L, Knapp R C. Adenocarcinoma of the uterine cervix: prognostic factors and patterns of recurrence. Gynecol Oncol. 33:1989;241-247.
3. Davis J R, Moon L B. Increased incidence of adenocarcinoma of the uterine cervix. Obstet Gynecol. 45:1975;79-83.
4. Greer B E, Figge D C, Tamimi H K, Cain J M. Stage 1B adenocarcinoma of the cervix treated by radical hysterectomy and pelvic lymph node dissection. Am J Obstet Gynecol. 160:1989;1508-1514.
5. Reagan J W, Ng A BP. Cellular Detection of Glandular Neoplasms of the Uterine Cervix. Weid G L. Compendium on Diagnostic Cytology. 1988;146-153 Tutorials of Clinical Cytology, Chicago.
6. Young R H, Scully R E. Invasive adenocarcinoma and related tumors of the uterine cervix. Semin Diagn Pathol. 7:1990;205-227.
7. Hurt W G, Silverberg S G, Frable W J, Belgrad R, Crooks L D Jr. Adenocarcinoma of the cervix. Histologic and clinical features. Am J Obstet Gynecol. 129:1977;304-315.
8. Lesley J, Hyman R, Kincade P W. CD44 and its interaction with extracellular matrix. Adv Immunol. 54:1993;271-335.
9. Gunthert U. CD44: a multitude of isoforms with diverse functions. Curr Top Microbiol Immunol. 184:1993;47-63.
10. Haynes B F, Telen M J, Hale L P, Denning S M. CD44: a molecule involved in leukocyte adherence and T-cell activation. Immunol Today. 10:1989;423-428.
11. Ponta H, Sleeman J, Dall P, Moll J, Sherman L, Herrlich P. CD44 isoforms in metastatic cancer. Invasion Metastasis. 14:1995;82-86.
12. Goodison S, Tarin D. Current status of CD44 variant isoforms as cancer diagnostic markers. Histopathology. 32:1998;1-6.
13. Tanabe K K, Ellis L M, Saya H. Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet. 341:1993;725-726.
14. Kawahara K, Yoshino T, Kawasaki N, Miyake K, Akagi T. Abnormal expression of human CD44 gene in early colorectal malignancy with special reference to variant exon 9 (9v). J Clin Pathol. 49:1996;478-481.
15. Liu A Y. Expression of CD44 in prostate cancer cells. Cancer Lett. 76:1994;63-69.
16. Nagabhushan M, Pretlow T G, Guo Y-J, Amini S B, Pretlow T P. Altered expression of CD44 in human prostate cancer during progression. Am J Clin Pathol. 106:1996;647-651.
17. Zhang X H, Sakamoto H, Takenaka I. Accumulation of p53 and expression of CD44 in human prostatic cancer and benign prostatic hyperplasia: an immunohistochemical study. Br J Urol. 77:1996;441-444.
18. Kan M, Furukawa A, Aki M, Kanayama H, Kagawa S. Expression of CD44 splice variants in bladder cancer. Int J Urol. 2:1995;295-301.
19. Sugino T, Gorham H, Yoshida K, Bolodeoku J, Nargund V, Cranston D, Goodison S, Tarin D. Progressive loss of CD44 gene expression in invasive bladder cancer. Am J Pathol. 149:1996;873-882.
20. Heider K H, Ratschek M, Zatloukal K, Adolf G R. Expression of CD44 isoforms in human renal cell carcinomas. Virchows Arch. 428:1996;267-273.
21. Terpe H J, Storkel S, Zimmer U, Anquez V, Fischer C, Pantel K, Gunthert U. Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation. Am J Pathol. 148:1996;453-463.
22. Kaaijk P, Troost D, Morsink F, Keehnen R M, Leenstra S, Bosch D A, Pals S T. Expression of CD44 splice variants in human primary brain tumors. J Neurooncol. 26:1995;185-190.
23. Eibl R H, Pietsch T, Moll J, Skroch Angel P, Heider K H, von Ammon K, Wiestler O D, Ponta H, Kleihues P, Herrlich P. Expression of variant CD44 epitopes in human astrocytic brain tumors. J Neurooncol. 26:1995;165-170.
24. Seelentag W K, Gunthert U, Saremaslani P, Futo E, Pfaltz M, Heitz P U, Roth J. CD44 standard and variant isoform expression in human epidermal skin tumors is not correlated with tumor aggressiveness but down-regulated during proliferation and tumor de-differentiation. Int J Cancer. 69:1996;218-224.
25. Prieto V G, Reed J A, McNutt N S, Bogdany J K, Lugo J, Shea C R. Differential expression of CD44 in malignant cutaneous epithelial neoplasms. Am J Dermatopathol. 17:1995;447-451.
26. Korabiowska M, Brinck U, Honig J, Mora O, Bartkowski S, Schauer A. CD-44: a marker of metastases of head and neck melanomas. In Vivo. 9:1995;253-256.
27. Perin T, Canzonieri V, Massarut S, Bidoli E, Rossi C, Roncadin M, Carbone A. Immunohistochemical evaluation of multiple biological markers in ductal carcinoma in situ of the breast. Eur J Cancer. 32A:1996;1148-1155.
28. de la Torre M, Heldin P, Bergh J. Expression of the CD44 glycoprotein (lymphocyte-homing receptor) in untreated human breast cancer and its relationship to prognostic markers. Anticancer Res. 15:1995;2791-2795.
29. Sinn H P, Heider K H, Skroch-Angel P, von Minckwitz G, Kaufmann M, Herrlich P, Ponta H. Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44. Breast Cancer Res Treat. 36:1995;307-313.
30. Dellas A, Schultheiss E, Almendral A C, Torhost J, Gudat F. Expression of CD44 and variant isoforms in cervical intraepithelial neoplasia. Gynecol Oncol. 62:1996;281-255.
31. Dall P, Heider K H, Hekele A, Minckwitz G, Kaufmann M, Ponta H, Herrlich P. Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium. Cancer Res. 54:1994;3337-3341.
32. Dall P, Hekele A, Ikenberg H, Goppinger A, Bauknecht T, Pfleiderer A, Moll J, Hofmann M, Ponta H, Herrlich P. Increasing incidence of CD44v7/8 epitope expression during uterine cervical carcinogenesis. Int J Cancer. 69:1996;79-85.
33. Kainz C, Kohlberger P, Sliutz G, Tempfer C, Heinzl H, Reinthaller A, Breitenecker G, Koelbl H. Splice variants of CD44 in human cervical cancer stage IB to IIB. Gynecol Oncol. 57:1995;382-387.
34. Kainz C, Kohlberger P, Tempfer C, Sliutz G, Gitsch G, Reinthaller A, Breitenecker G. Prognostic value of CD44 splice variants in human stage III cervical cancer. Eur J Cancer. 31A:1995;1706-1709.
35. McGonigle K F, Berek J S. Early stage squamous cell and adenocarcinoma of the cervix. Curr Opin Obstet Gynecol. 4:1992;109-119.
36. Kennedy A W, Salmieri S S, Wirth S L, Biscotti C V, Tuason L J, Travarca M J. Results of the clinical evaluation of atypical glandular cells of undetermined significance (AGCUS) detected on cervical cytology screening. Gynecol Oncol. 63:1996;14-18.
37. Lee K R, Manna E A, John T St. Atypical endocervical glandular cells: accuracy of cytologic diagnosis. Diagn Cytopathol. 13:1995;202-208.
38. Castella E, Ariza A, Fernandez-Vasalo A, Roca X, Ojanguren I. Expression of CD44H and CD44v3 in normal oesophagus, Barrett mucosa and oesophageal carcinoma. J Clin Pathol. 49:1996;489-492.
39. Sliutz G, Tempfer C, Winkler S, Kohlberger P, Reinthaller A, Kainz C. Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer. Br J Cancer. 72:1995;1494-1497.
40. Seelentag W K, Flury R, Schmid M, Komminoth P, Saremaslani P, Gunthert U, Heitz P U, Roth J. Expression of CD44 isoforms in normal human liver and also in regenerative and neoplastic liver changes. Verh Dtsch Ges Pathol. 79:1995;144-147.